CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,784 shares at $21.05 ($37,553)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 18,924 shares at $21.05 ($398,350)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 1,771 shares at $21.05 ($37,280)
- 4 Planned sale Chief Research Officer sold 3,198 shares at $21.05 ($67,318)
- 4 Planned sale Chief Legal Officer and GC sold 4,920 shares at $21.05 ($103,566)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K/A Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Acquisition or sale completed
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
Page 12 of 65 · 1,286 filings